MENU
MANE
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Veradermics (MANE) Ownership - Who owns Veradermics?

Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.42B
P/E Ratio
N/A
Total Cash
390.8M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.35
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
MANE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details